Innovative Delivery Technology Oval Medical Technologies specializes in revolutionary autoinjector platforms that are smaller, safer, and easier to use, providing a competitive edge in the market for delivering viscous and sensitive biological drugs, creating opportunities to partner with pharmaceutical companies seeking advanced injection solutions.

Patient-Centric Design Their ability to tailor devices for specific patient populations positions Oval as a preferred partner for pharma companies focused on patient convenience and compliance, opening avenues for collaborative development of custom injection devices for niche or emerging markets.

Strategic Facility Expansion Recent move to a purpose-designed facility in Cambridge Research Park reflects growth and increased production capacity, which can support larger pharmaceutical clients and clinical trials requiring more extensive device manufacturing and integration services.

Part of a Manufacturing Ecosystem As part of the SMC Group, which offers comprehensive contracting and manufacturing services for medical devices, Oval can leverage this network for integrated supply chain solutions, component sourcing, and device assembly, appealing to clients needing end-to-end manufacturing support.

Aligned with Industry Trends With a focus on autoinjector innovation and patient-centric devices amidst rising demand for injectables in biologics and personalized medicine, Oval is well positioned to capitalize on current market trends and expand collaborations with biotech and pharma organizations seeking advanced injection technologies.